Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

Y Geng1, R A Weinberg

  • 1Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge 02142.

Insights

Transforming growth factor beta 1 (TGF-beta 1) inhibits cell growth by preventing retinoblastoma protein (pRb) hyperphosphorylation. This occurs by altering the expression of G1 cyclins and kinases, impacting cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor beta 1 (TGF-beta 1) is a known inhibitor of cell proliferation.
  • TGF-beta 1's growth-inhibitory mechanism is linked to its effect on retinoblastoma protein (pRb) hyperphosphorylation.
  • Cell cycle-regulated kinases are implicated in the hyperphosphorylation of pRb.

Purpose of the Study:

  • To investigate the molecular mechanisms by which TGF-beta 1 inhibits cell growth.
  • To elucidate the effects of TGF-beta 1 on the expression of G1 cyclins and their associated kinases.
  • To understand how TGF-beta 1 influences pRb hyperphosphorylation and cell cycle progression.

Main Methods:

  • Analysis of gene expression related to G1 cyclins and associated kinases.
  • Investigation of TGF-beta 1's impact on pRb hyperphosphorylation.
  • Assessment of TGF-beta 1's effects on the cell cycle apparatus.

Main Results:

  • TGF-beta 1 significantly affects the expression of genes encoding specific G1 cyclins.
  • TGF-beta 1 influences the expression of kinases associated with G1 cyclins.
  • These alterations in gene expression provide a mechanism for TGF-beta 1's effect on pRb hyperphosphorylation.

Conclusions:

  • TGF-beta 1's growth-inhibitory effects are mediated through its modulation of G1 cyclin and kinase gene expression.
  • This modulation impacts pRb hyperphosphorylation, a key event in cell cycle control.
  • TGF-beta 1 influences the cell cycle apparatus responsible for G1 phase transit, explaining its antiproliferative action.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...